Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 800.239.2901

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Is FDA Taking Close Enough Look at Fast-Tracked Drugs?Steep Price Hikes Led to Drop in Use of 2 Heart Drugs at U.S. HospitalsAPA: Medical Discrimination Based on Size Stresses Patients2 of 3 U.S. Patients Keep Unused Painkillers After SurgeryMedical Reality Catches Up to Science FictionFDA Looks to Reduce Nicotine in CigarettesAHA Hands-Only CPR Training Kiosks Available at More Airports$100 Sweetens the Pot for a ColonoscopyJust a Few Vaccine Refusers Could Endanger ManyASCO Addresses Cancer Drug PricingHigh Court Rules Against Interstate Medical LiabilityFewer U.S. Dollars Spent on Cardiac Arrest Research: StudyPainkiller Prescriptions More Prone to Errors If HandwrittenFDA Panel OKs What May Soon Be First Gene Therapy Approved in U.S.Walking Rates Are Key to a Country's Obesity LevelsDocs Should Counsel Even Healthy People on Diet, Exercise, Experts SayHealth Service Use Unchanged From 1996-1997 to 2011-2012Easier Colon Exam Boosts Screening, But Insurers May Not PayMore U.S. Patients Are Recording Their Doctor VisitsMedication Mistakes Have Doubled in U.S. Since 2000: StudyMarket Competition Linked to Change in Generic Drug PricesBlood Shortage Prompts Call for DonationsBullying Takes Financial Toll on U.S. School DistrictsPoll Finds Seniors Struggling With Drug Costs Don't Seek HelpMany U.S. Teens Still Denied 'Morning After' Pill at PharmaciesOlder Americans Struggling With Drug Costs Don't Ask for HelpDoctors Urged to Take Care With Electronic CommunicationsClimate Change Likely to Widen Gap Between Rich, Poor in U.S.: StudyFDA Seeks to Increase Number of Generic Drugs on Market3 Simple Steps Might Reduce Opioid OD DeathsPhysician Attitude Important Factor in Patients Switching PCPMany Adverse Events Related to Cosmetics Go UnreportedStudy Highlights the Beauty Industry's Ugly SideMedicaid Cuts Tied to Delayed Breast Cancer DiagnosesPrimary Care Pharmacy Model Attractive to Patients1991-2014 Saw Minimal Change in Health Spending Per StateLegalized Pot May Lead to More Traffic CrashesMany Doctors Silent on Cost of Cancer CareGroup Urges Tougher Limits on Chemical in Shampoos, Cosmetics18 Percent Increase Projected in Primary Care Demand by 2023Why Patients Leave the Hospital Against Doctor's OrdersRaise the Smoking Age to 21? Most Kids Fine With ThatComprehensive Audiologic Care Feasible in Free Clinic ModelMany Tanning Salons Defy Legal Age Limits on UsersLifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyFDA Puts Brakes on Rule Requiring New 'Nutrition Facts' LabelCardiac Arrest? Someday, Drones May Come to Your RescueSAMHSA: 9.8 Million U.S. Adults Have Serious Mental Illness
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

No Routine Screening for Thyroid Cancer: Expert Panel

HealthDay News
by -- Mary Elizabeth Dallas
Updated: May 9th 2017

new article illustration

TUESDAY, May 9, 2017 (HealthDay News) -- Doctors shouldn't routinely screen adults for thyroid cancer if they have no symptoms or warning signs of the disease, according to the U.S. Preventative Services Task Force (USPSTF).

Doing so could cause more harm than good, said the independent panel of experts as it reaffirmed guidelines it issued in 1996 and 2016.

"While there is very little evidence of the benefits of screening for thyroid cancer, there is considerable evidence of the serious harms of treatment, such as damage to the nerves that control speaking and breathing," said panel member Karina Davidson in a USPSTF news release.

"What limited evidence is available does not suggest that screening enables people to live longer, healthier lives," she said.

The thyroid is a hormone-producing gland located in the neck. The hormones produced by the thyroid help regulate the body's metabolism. There is more than one type of thyroid cancer, but the disease is rare in the United States. Thyroid cancer represents less than 4 percent of all new cancer diagnoses in 2017, the USPSTF said.

The task force reviewed the available evidence on the benefits and risks of screening.

And while screening for the disease does increase the number of people diagnosed with thyroid cancer, it doesn't reduce death rates associated with the disease, the USPSTF concluded.

"Overdiagnosis occurs because screening for thyroid cancer often identifies small or slow growing tumors that might never affect a person during their lifetime," said USPSTF member Dr. Seth Landefeld.

"People who are treated for these small tumors are exposed to serious risks from surgery or radiation, but do not receive any real benefit," he said.

The USPSTF recommendation was published online May 9 in the Journal of the American Medical Association. It is also on the USPSTF website at www.uspreventiveservicestaskforce.org.

More information

The American Cancer Society provides more information on thyroid cancer.